Clinical Trials

Showing trials with last updates posted in 2026.

NCT02484404 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
268 participants

Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2015-06-29
Completion:
2027-10-30
Conditions
  • Colorectal Neoplasms
  • Breast Neoplasms
Interventions
  • DRUG
No Results Yet
NCT01467869 | RECRUITING
100 participants

Male Fertility Program

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
1991-01-31
Completion:
2036-12-31
Conditions
  • Spinal Cord Injury
No Results Yet
NCT01266642 | ACTIVE_NOT_RECRUITING | PHASE2
301 participants

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2011-02-08
Completion:
2020-11-30
Conditions
  • Ductal Breast Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage I Breast Cancer AJCC v6
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
Interventions
  • RADIATION
  • OTHER
NCT00720785 | COMPLETED | PHASE1
35 participants

Natural Killer Cells and Bortezomib to Treat Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2008-08-01
Completion:
2021-04-06
Conditions
  • Chronic Myeloid Leukemia (CML)
  • Pancreatic Ca
  • Colon/Rectal Ca
  • Multiple Myeloma
  • Carcinoma, Non-Small -Cell Lung
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page